C
Camp4 Therapeutics Corporation (CAMP)
NGM – Real Time Price. Currency in USD
4.20
+0.28 (7.14%)
At close: Jun 26, 2026, 4:00 PM EDT
4.20
0.00 (0.00%)
After-hours: Jun 26, 2026, 5:41 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
4.20
+0.28 (7.14%)
At close: Jun 26, 2026, 4:00 PM EDT
4.20
0.00 (0.00%)
After-hours: Jun 26, 2026, 5:41 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $99.9M significantly exceed its total debt $2.1M, ensuring strong financial flexibility
Total current assets $102.2M exceed Total current liabilities $16.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$11.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.15 | 6.05 | 10 | |
| Quick ratio | 6.15 | 5.63 | 10 | |
| Debt to Equity | 0.07 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 350K | 652K | 3M | 4M |
| Gross Profit | -947K | -1M | -1M | 2M | 2M |
| Operating Income | -45M | -52M | -53M | -52M | -52M |
| Net Income | -44M | -49M | -52M | -80M | -86M |
| EBITDA | -44M | -50M | -51M | -50M | -50M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 8.16 | 65.9 | 8.0 |
| Next quarter | 103.67 | 68.05 | 10 |
| Current year | 77.91 | 69.33 | 10 |
| Next year | -6.12 | 9.67 | 3.5 |
| Weighted average score | 7.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 271.84 | 54.5 | 62.79 | -274.49 | 7.8 |
| Y/Y | 50.82 | -47.43 | 48.39 | 24.61 | 7.8 |
| 3y average | 507.26 | -23.93 | N/A | 7.84 | 4.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 5.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |